FIDAXOMICIN

FIDAXOMICIN was reported 2417 times

FIDAXOMICIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HIV INFECTION CDC GROUP I 1 0.3333
1 FLUID BALANCE POSITIVE 4 0.2667
2 AVIAN INFLUENZA 13 0.2031
3 DIENTAMOEBA INFECTION 2 0.1429
4 PROBIOTIC THERAPY 11 0.1111
5 CLOSTRIDIUM TEST NEGATIVE 1 0.1000
6 INTESTINAL ATONY 4 0.0656
7 RENAL GRAFT INFECTION 13 0.0560
8 DRUG DISPENSING ISSUE 1 0.0526
9 CHEMOKINE INCREASED 1 0.0370
10 CLOSTRIDIUM TEST 1 0.0323
11 AGONAL DEATH STRUGGLE 1 0.0250
12 CLOSTRIDIUM TEST POSITIVE 55 0.0249
13 BRAIN STEM ISCHAEMIA 4 0.0223
14 CLOSTRIDIUM DIFFICILE INFECTION 484 0.0222
15 WEANING FAILURE 8 0.0220
16 URINARY TRACT INFECTION PSEUDOMONAL 13 0.0216
17 ADIPOSIS DOLOROSA 1 0.0208
18 ISCHAEMIC ENTERITIS 2 0.0206
19 PEPTIC ULCER PERFORATION 6 0.0199
20 PARVOVIRUS INFECTION 8 0.0198
21 ABDOMINAL REBOUND TENDERNESS 2 0.0179
22 COMMUNITY ACQUIRED INFECTION 1 0.0179
23 MEGACOLON 24 0.0153
24 CLOSTRIDIUM DIFFICILE COLITIS 162 0.0153
25 MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN 1 0.0139
26 TERMINAL ILEITIS 8 0.0130
27 ALPHA-1 ANTITRYPSIN DEFICIENCY 1 0.0114
28 PSEUDOMEMBRANOUS COLITIS 23 0.0103
29 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 3 0.0101
30 PERIPHERAL CIRCULATORY FAILURE 4 0.0098
31 BILIARY DRAINAGE 1 0.0096
32 SUPERFICIAL VEIN THROMBOSIS 8 0.0095
33 ESCHERICHIA TEST POSITIVE 11 0.0092
34 DYSBIOSIS 7 0.0085
35 EPSTEIN-BARR VIRAEMIA 9 0.0081
36 LARYNGEAL ULCERATION 1 0.0077
37 KLEBSIELLA TEST POSITIVE 5 0.0077
38 CULTURE STOOL POSITIVE 2 0.0073
39 GRAFT VERSUS HOST DISEASE IN LIVER 5 0.0070
40 GASTRIC MUCOSAL LESION 5 0.0069
41 ALLOGENIC STEM CELL TRANSPLANTATION 1 0.0063
42 HYPERMAGNESAEMIA 4 0.0061
43 GASTROINTESTINAL MUCOSAL DISORDER 4 0.0061
44 CYTOMEGALOVIRUS ENTERITIS 2 0.0056
45 HISTOPLASMOSIS 9 0.0051
46 HERPES DERMATITIS 1 0.0050
47 CYTOMEGALOVIRUS VIRAEMIA 22 0.0049
48 OEDEMA MUCOSAL 5 0.0048
49 BACTERIAL DIARRHOEA 1 0.0047
50 CLOSTRIDIAL INFECTION 16 0.0047
51 ADULT FAILURE TO THRIVE 1 0.0047
52 HERPES OESOPHAGITIS 1 0.0047
53 HYPERFERRITINAEMIA 2 0.0046
54 HISTAMINE LEVEL INCREASED 1 0.0046
55 ADENOVIRUS INFECTION 13 0.0045
56 OESOPHAGEAL INFECTION 2 0.0045
57 LASER THERAPY 1 0.0044
58 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 4 0.0042
59 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 1 0.0042
60 NAIL BED INFECTION 1 0.0042
61 ENTEROBACTER TEST POSITIVE 1 0.0041
62 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 5 0.0040
63 PHARYNGEAL ABSCESS 2 0.0040
64 SEPSIS SYNDROME 2 0.0040
65 MEAN ARTERIAL PRESSURE DECREASED 1 0.0040
66 DISEASE RECURRENCE 179 0.0038
67 EAR INFECTION BACTERIAL 1 0.0037
68 MUCOUS STOOLS 18 0.0036
69 COLONIC PSEUDO-OBSTRUCTION 1 0.0036
70 ABDOMINAL WALL DISORDER 1 0.0034
71 ESCHERICHIA BACTERAEMIA 8 0.0034
72 GASTROINTESTINAL MUCOSA HYPERAEMIA 1 0.0034
73 PANCREATITIS CHRONIC 8 0.0034
74 ADENOCARCINOMA GASTRIC 3 0.0032
75 DERMATITIS EXFOLIATIVE GENERALISED 11 0.0032
76 INTESTINAL ULCER 5 0.0031
77 HEPATIC INFECTION 4 0.0031
78 SPINAL CORD INFECTION 2 0.0031
79 BICYTOPENIA 6 0.0031
80 CHRONIC MYELOMONOCYTIC LEUKAEMIA 2 0.0030
81 SPUTUM ABNORMAL 2 0.0030
82 ARRHYTHMIC STORM 1 0.0030
83 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
84 PATHOGEN RESISTANCE 27 0.0030
85 ABSCESS NECK 2 0.0030
86 LARGE INTESTINAL ULCER HAEMORRHAGE 1 0.0029
87 PAINFUL DEFAECATION 2 0.0029
88 GASTROENTERITIS CLOSTRIDIAL 1 0.0028
89 FUNGAL TEST POSITIVE 1 0.0028
90 BRONCHIAL OBSTRUCTION 4 0.0028
91 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
92 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
93 CHRONIC RESPIRATORY DISEASE 1 0.0028
94 KLEBSIELLA INFECTION 14 0.0028
95 LOWER URINARY TRACT SYMPTOMS 1 0.0028
96 ACINETOBACTER INFECTION 3 0.0027
97 HEPATOSPLENOMEGALY 7 0.0027
98 LISTERIOSIS 3 0.0027
99 OSMOTIC DEMYELINATION SYNDROME 2 0.0027
100 HYDROURETER 1 0.0026
101 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 2 0.0026
102 AMYOTROPHY 1 0.0026
103 BRONCHIAL DISORDER 4 0.0026
104 HYPOVOLAEMIA 15 0.0026
105 ABNORMAL FAECES 21 0.0026
106 DIARRHOEA INFECTIOUS 2 0.0025
107 BONE MARROW TOXICITY 3 0.0025
108 CLOSTRIDIUM COLITIS 3 0.0025
109 DEATH OF RELATIVE 1 0.0025
110 GASTROENTERITIS SALMONELLA 2 0.0024
111 LIVEDO RETICULARIS 5 0.0024
112 FOOD AVERSION 4 0.0024
113 COLONOSCOPY ABNORMAL 1 0.0023
114 PUPIL FIXED 4 0.0023
115 PRODUCT CONTAINER SEAL ISSUE 4 0.0023
116 PANCREATIC FAILURE 4 0.0023
117 HYPERNATRAEMIA 11 0.0022
118 LAPAROTOMY 1 0.0022
119 HYPERURICAEMIA 9 0.0022
120 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
121 FAECAL VOLUME DECREASED 1 0.0021
122 ENTEROCOLITIS 12 0.0021
123 DEPENDENCE ON OXYGEN THERAPY 1 0.0020
124 MYELOID LEUKAEMIA 1 0.0020
125 HYPERPARATHYROIDISM SECONDARY 5 0.0020
126 MENINGITIS LISTERIA 1 0.0020
127 FAECAL VOLUME INCREASED 1 0.0019
128 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
129 PRODUCT DISPENSING ISSUE 8 0.0019
130 ENTEROCOCCAL INFECTION 9 0.0019
131 ENZYME ABNORMALITY 1 0.0019
132 HYPEREOSINOPHILIC SYNDROME 1 0.0018
133 MILK ALLERGY 1 0.0018
134 INTERLEUKIN LEVEL INCREASED 1 0.0018
135 SYSTEMIC INFECTION 3 0.0018
136 COLECTOMY TOTAL 1 0.0018
137 HEPATORENAL SYNDROME 3 0.0018
138 CACHEXIA 9 0.0017
139 INFECTION REACTIVATION 2 0.0017
140 CYTOMEGALOVIRUS COLITIS 4 0.0017
141 ENTERAL NUTRITION 1 0.0017
142 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
143 TRANSPLANT 4 0.0017
144 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
145 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
146 OTITIS EXTERNA 2 0.0016
147 GASTROINTESTINAL SOUNDS ABNORMAL 8 0.0016
148 BACILLUS INFECTION 1 0.0016
149 ESCHERICHIA INFECTION 13 0.0016
150 HAEMODYNAMIC INSTABILITY 12 0.0016
151 PRODUCT PRESCRIBING ISSUE 34 0.0016
152 AGRANULOCYTOSIS 29 0.0016
153 AUTOIMMUNE COLITIS 1 0.0016
154 PNEUMONIA FUNGAL 6 0.0015
155 BONE OPERATION 1 0.0015
156 HEAD AND NECK CANCER 1 0.0015
157 INFECTIOUS PERITONITIS 1 0.0015
158 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 11 0.0015
159 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
160 TREATMENT FAILURE 120 0.0014
161 RASH MORBILLIFORM 4 0.0014
162 DYSPNOEA AT REST 4 0.0014
163 PULMONARY SEPSIS 2 0.0014
164 DIET REFUSAL 1 0.0014
165 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
166 BLUNTED AFFECT 1 0.0014
167 ILEUS PARALYTIC 6 0.0013
168 PROTEIN TOTAL DECREASED 5 0.0013
169 DISTRIBUTIVE SHOCK 3 0.0013
170 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
171 CONTRAINDICATION TO MEDICAL TREATMENT 2 0.0013
172 PANCREATITIS NECROTISING 3 0.0013
173 CREATINE KINASE INCREASED 1 0.0013
174 MELAENA 28 0.0013
175 INHIBITORY DRUG INTERACTION 2 0.0013
176 HISTOPLASMOSIS DISSEMINATED 2 0.0013
177 NEUTROPENIC SEPSIS 9 0.0013
178 PNEUMONIA ASPIRATION 31 0.0012
179 ENTEROCOCCAL SEPSIS 1 0.0012
180 RESPIRATORY ALKALOSIS 2 0.0012
181 BOTULISM 1 0.0012
182 FUNGAL SEPSIS 1 0.0012
183 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 6 0.0012
184 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
185 HEPATITIS A 1 0.0012
186 INFECTED BITE 1 0.0012
187 HEPATIC CYTOLYSIS 15 0.0012
188 ILEOSTOMY 3 0.0012
189 MYCOTIC ALLERGY 1 0.0012
190 GASTROENTERITIS 17 0.0012
191 BLOOD CHLORIDE INCREASED 2 0.0012
192 POOR QUALITY PRODUCT ADMINISTERED 12 0.0011
193 LUNG OPACITY 3 0.0011
194 ABDOMINAL SEPSIS 1 0.0011
195 GASTROINTESTINAL OEDEMA 2 0.0011
196 HYPERLEUKOCYTOSIS 1 0.0011
197 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
198 CANDIDA SEPSIS 1 0.0011
199 CATHETER MANAGEMENT 1 0.0011
200 INCORRECT PRODUCT ADMINISTRATION DURATION 24 0.0011
201 ANAEMIA OF CHRONIC DISEASE 1 0.0011
202 ARTERIOVENOUS MALFORMATION 1 0.0011
203 FAECES SOFT 8 0.0011
204 ACUTE GRAFT VERSUS HOST DISEASE 5 0.0011
205 CONTRAST MEDIA ALLERGY 2 0.0011
206 DRUG RESISTANCE 28 0.0011
207 PRODUCT DISTRIBUTION ISSUE 10 0.0011
208 DUODENAL ULCER PERFORATION 8 0.0011
209 ADVERSE FOOD REACTION 1 0.0011
210 SEPTIC SHOCK 46 0.0011
211 MECHANICAL VENTILATION 2 0.0011
212 PSEUDOMONAS INFECTION 9 0.0010
213 INTUSSUSCEPTION 1 0.0010
214 HERPES VIRUS INFECTION 6 0.0010
215 BLADDER CATHETERISATION 1 0.0010
216 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
217 APLASIA 2 0.0010
218 DUST ALLERGY 1 0.0010
219 INABILITY TO AFFORD MEDICATION 10 0.0010
220 ABDOMINAL TENDERNESS 5 0.0010
221 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
222 BLEPHARITIS 4 0.0010
223 MIXED LIVER INJURY 3 0.0010
224 MUCOSAL ULCERATION 1 0.0010
225 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 5 0.0010
226 GRAFT VERSUS HOST DISEASE 7 0.0010
227 DERMATITIS BULLOUS 7 0.0010
228 FAECAL CALPROTECTIN INCREASED 3 0.0009
229 ALLERGY TO ANIMAL 1 0.0009
230 ACARODERMATITIS 1 0.0009
231 ADRENAL INSUFFICIENCY 11 0.0009
232 CYTOMEGALOVIRUS INFECTION 15 0.0009
233 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
234 LARGE INTESTINAL OBSTRUCTION 2 0.0009
235 COLECTOMY 5 0.0009
236 BLOOD LOSS ANAEMIA 2 0.0009
237 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 22 0.0009
238 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 5 0.0008
239 HYPOVOLAEMIC SHOCK 4 0.0008
240 APHAGIA 4 0.0008
241 CHRONIC RESPIRATORY FAILURE 1 0.0008
242 MALNUTRITION 9 0.0008
243 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
244 SYSTEMIC CANDIDA 2 0.0008
245 OSTEITIS 2 0.0008
246 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
247 COVID-19 PNEUMONIA 9 0.0008
248 ORAL CANDIDIASIS 10 0.0008
249 SERUM FERRITIN INCREASED 4 0.0008
250 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
251 PRODUCT RESIDUE PRESENT 4 0.0007
252 NO THERAPEUTIC RESPONSE 9 0.0007
253 ABDOMINAL RIGIDITY 2 0.0007
254 CARBON DIOXIDE INCREASED 1 0.0007
255 INFUSION SITE RASH 1 0.0007
256 HYPERCALCAEMIA 9 0.0007
257 INCISIONAL HERNIA 1 0.0007
258 STREPTOCOCCAL INFECTION 4 0.0007
259 LEUKOCYTOSIS 13 0.0007
260 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
261 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
262 LUNG CONSOLIDATION 2 0.0007
263 THERAPEUTIC RESPONSE DELAYED 2 0.0007
264 ANAL HAEMORRHAGE 2 0.0007
265 CULTURE URINE POSITIVE 1 0.0007
266 BLOOD ELECTROLYTES DECREASED 1 0.0007
267 CHORIORETINOPATHY 1 0.0007
268 PRODUCT SUPPLY ISSUE 5 0.0007
269 ESCHERICHIA SEPSIS 2 0.0007
270 RASH PUSTULAR 5 0.0007
271 HYPOXIA 24 0.0007
272 GENERALISED ANXIETY DISORDER 1 0.0007
273 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
274 RASH MACULO-PAPULAR 15 0.0007
275 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
276 HYPERCAPNIA 2 0.0007
277 CENTRAL VENOUS CATHETERISATION 2 0.0007
278 AGE-RELATED MACULAR DEGENERATION 1 0.0007
279 INTELLECTUAL DISABILITY 1 0.0007
280 MARASMUS 1 0.0007
281 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
282 IMMUNE THROMBOCYTOPENIA 3 0.0007
283 BLOOD PRESSURE IMMEASURABLE 1 0.0007
284 DEVICE RELATED INFECTION 10 0.0006
285 DIFFUSE LARGE B-CELL LYMPHOMA 5 0.0006
286 GASTROSTOMY 1 0.0006
287 FUNGAEMIA 1 0.0006
288 INTESTINAL OPERATION 1 0.0006
289 BLOOD ALBUMIN DECREASED 5 0.0006
290 FAECAL INCONTINENCE 3 0.0006
291 VENTRICULAR HYPOKINESIA 2 0.0006
292 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
293 DENTAL IMPLANTATION 1 0.0006
294 OTITIS MEDIA 2 0.0006
295 NEPHRITIS 2 0.0006
296 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
297 ENTERITIS INFECTIOUS 1 0.0006
298 BLOOD PH DECREASED 1 0.0006
299 ANURIA 5 0.0006
300 MYCOBACTERIAL INFECTION 1 0.0006
301 COLITIS 22 0.0006
302 INCORRECT STORAGE OF DRUG 1 0.0006
303 LARGE INTESTINE PERFORATION 4 0.0006
304 CHOLESTASIS 11 0.0006
305 DEFAECATION URGENCY 4 0.0006
306 BURNS SECOND DEGREE 1 0.0006
307 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
308 BRONCHIOLITIS 2 0.0006
309 JAUNDICE CHOLESTATIC 2 0.0006
310 FEAR OF DISEASE 1 0.0006
311 JOINT ARTHROPLASTY 1 0.0006
312 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
313 APPARENT DEATH 2 0.0006
314 NORMAL NEWBORN 3 0.0006
315 PRODUCT DISPENSING ERROR 12 0.0006
316 DIARRHOEA 354 0.0005
317 RECTAL DISCHARGE 2 0.0005
318 AMYLASE INCREASED 2 0.0005
319 BLADDER SPASM 1 0.0005
320 PERITONITIS 11 0.0005
321 BLOOD BICARBONATE DECREASED 1 0.0005
322 PRODUCT STORAGE ISSUE 2 0.0005
323 NEUTROPHILIA 3 0.0005
324 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
325 HYPOKALAEMIA 24 0.0005
326 ARTERIAL THROMBOSIS 1 0.0005
327 ELECTROLYTE IMBALANCE 6 0.0005
328 ALCOHOL INTERACTION 1 0.0005
329 EOSINOPHILIA 9 0.0005
330 EPIGASTRIC DISCOMFORT 2 0.0005
331 FLATULENCE 29 0.0005
332 COLOSTOMY 1 0.0005
333 RESPIRATORY FAILURE 37 0.0005
334 FAECES DISCOLOURED 11 0.0005
335 CELL DEATH 1 0.0005
336 PANCYTOPENIA 28 0.0005
337 CARDIAC DISCOMFORT 1 0.0005
338 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
339 HEPATOCELLULAR INJURY 7 0.0005
340 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 1 0.0005
341 ARTHRITIS BACTERIAL 2 0.0005
342 CHANGE OF BOWEL HABIT 1 0.0005
343 HYPERPARATHYROIDISM 1 0.0005
344 NO ADVERSE EVENT 86 0.0005
345 PROTEINURIA 9 0.0005
346 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
347 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
348 ACUTE RESPIRATORY FAILURE 9 0.0005
349 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
350 TONGUE DISCOLOURATION 2 0.0005
351 HYPERKALAEMIA 16 0.0005
352 COLONOSCOPY 1 0.0005
353 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
354 FAECES PALE 1 0.0004
355 CYTOKINE RELEASE SYNDROME 9 0.0004
356 BACTERIAL TEST POSITIVE 1 0.0004
357 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
358 FEAR OF DEATH 1 0.0004
359 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
360 METASTASES TO MENINGES 1 0.0004
361 SEPSIS 49 0.0004
362 PRODUCT AVAILABILITY ISSUE 10 0.0004
363 GASTRIC HAEMORRHAGE 5 0.0004
364 NEPHROGENIC ANAEMIA 2 0.0004
365 ROSACEA 2 0.0004
366 HALLUCINATION, VISUAL 9 0.0004
367 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
368 CONTRAST MEDIA REACTION 1 0.0004
369 HAEMATOLOGICAL INFECTION 1 0.0004
370 CYTOPENIA 5 0.0004
371 FREQUENT BOWEL MOVEMENTS 11 0.0004
372 METABOLIC ACIDOSIS 13 0.0004
373 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
374 STAPHYLOCOCCAL SEPSIS 2 0.0004
375 FOOT OPERATION 2 0.0004
376 ILEUS 5 0.0004
377 HEPATIC ENZYME ABNORMAL 2 0.0004
378 HYPERAMMONAEMIA 2 0.0004
379 CATHETER SITE HAEMORRHAGE 1 0.0004
380 BOWEL MOVEMENT IRREGULARITY 3 0.0004
381 CANCER PAIN 1 0.0004
382 BLOOD CHLORIDE DECREASED 1 0.0004
383 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
384 MUCORMYCOSIS 1 0.0004
385 END STAGE RENAL DISEASE 7 0.0004
386 WEIGHT FLUCTUATION 4 0.0004
387 COLITIS ULCERATIVE 17 0.0004
388 BLOOD LACTIC ACID INCREASED 2 0.0004
389 TOOTH INFECTION 5 0.0004
390 ABDOMINAL PAIN 88 0.0004
391 ANORECTAL DISCOMFORT 2 0.0004
392 ANIMAL BITE 1 0.0004
393 ANAL FISSURE 2 0.0004
394 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
395 ANAESTHETIC COMPLICATION 1 0.0004
396 GINGIVITIS 2 0.0004
397 BLOOD SODIUM INCREASED 1 0.0004
398 CHEILITIS 2 0.0004
399 DECUBITUS ULCER 3 0.0004
400 GASTRIC PERFORATION 1 0.0004
401 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
402 HAEMATOCHEZIA 20 0.0004
403 HEART RATE ABNORMAL 2 0.0004
404 THERAPY NON-RESPONDER 16 0.0004
405 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
406 NEUROLOGICAL SYMPTOM 2 0.0003
407 LOCAL SWELLING 6 0.0003
408 BILIARY COLIC 1 0.0003
409 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
410 ACUTE KIDNEY INJURY 52 0.0003
411 PURPURA 3 0.0003
412 BACTERAEMIA 4 0.0003
413 ODYNOPHAGIA 2 0.0003
414 BRAIN HERNIATION 1 0.0003
415 GASTROINTESTINAL INFECTION 3 0.0003
416 ANAL INCONTINENCE 3 0.0003
417 CRANIOCEREBRAL INJURY 1 0.0003
418 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
419 SMALL INTESTINAL OBSTRUCTION 4 0.0003
420 CHILLS 38 0.0003
421 PIGMENTATION DISORDER 2 0.0003
422 MULTIPLE-DRUG RESISTANCE 1 0.0003
423 BACTERIAL INFECTION 6 0.0003
424 INFUSION SITE EXTRAVASATION 2 0.0003
425 DIARRHOEA HAEMORRHAGIC 3 0.0003
426 DRUG INEFFECTIVE 419 0.0003
427 EOSINOPHILIC PNEUMONIA 1 0.0003
428 DRUG EFFECT INCREASED 1 0.0003
429 HEAD INJURY 10 0.0003
430 PULMONARY OEDEMA 14 0.0003
431 OCCUPATIONAL EXPOSURE TO PRODUCT 2 0.0003
432 PROCTALGIA 2 0.0003
433 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
434 HEPATITIS ACUTE 2 0.0003
435 PHARYNGEAL SWELLING 3 0.0003
436 DYSPHAGIA 29 0.0003
437 HYPOGAMMAGLOBULINAEMIA 2 0.0003
438 INFUSION SITE HAEMORRHAGE 1 0.0003
439 PULMONARY CONGESTION 4 0.0003
440 CORONAVIRUS INFECTION 2 0.0003
441 PRESCRIBED UNDERDOSE 6 0.0003
442 MENINGITIS 2 0.0003
443 TERMINAL STATE 2 0.0003
444 BK VIRUS INFECTION 1 0.0003
445 COLITIS ISCHAEMIC 2 0.0003
446 HEPATIC CYST 1 0.0003
447 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
448 BLOOD CREATININE ABNORMAL 1 0.0003
449 HYPOPNOEA 1 0.0003
450 INCONTINENCE 3 0.0003
451 NECROTISING FASCIITIS 1 0.0003
452 MACULOPATHY 1 0.0003
453 IRRITABLE BOWEL SYNDROME 6 0.0003
454 LIVER FUNCTION TEST INCREASED 6 0.0003
455 PRODUCT USE ISSUE 52 0.0003
456 HYPOKINESIA 4 0.0003
457 CUTANEOUS VASCULITIS 1 0.0003
458 ASPIRATION 3 0.0003
459 ASTHMATIC CRISIS 1 0.0003
460 HEPATITIS 7 0.0003
461 ORAL DISORDER 2 0.0003
462 GASTROINTESTINAL PAIN 3 0.0003
463 VENTRICULAR FIBRILLATION 3 0.0003
464 ABDOMINAL DISTENSION 28 0.0003
465 INTESTINAL PERFORATION 3 0.0003
466 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
467 REBOUND EFFECT 3 0.0003
468 HYPOCALCAEMIA 5 0.0003
469 DRUG DISPENSING ERROR 4 0.0003
470 GASTRIC INFECTION 1 0.0003
471 LIPASE INCREASED 2 0.0003
472 ADVERSE EVENT 24 0.0003
473 FAECES HARD 1 0.0003
474 APNOEA 2 0.0003
475 KIDNEY INFECTION 5 0.0003
476 RESPIRATORY DISTRESS 7 0.0003
477 CANDIDIASIS 1 0.0002
478 FRUSTRATION TOLERANCE DECREASED 2 0.0002
479 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
480 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
481 BLOOD CREATININE INCREASED 16 0.0002
482 POLYURIA 2 0.0002
483 GOITRE 1 0.0002
484 ACUTE CORONARY SYNDROME 2 0.0002
485 LIP SWELLING 8 0.0002
486 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
487 ABDOMINAL PAIN LOWER 6 0.0002
488 INFUSION SITE ERYTHEMA 2 0.0002
489 MUSCLE FATIGUE 1 0.0002
490 CARDIAC FAILURE CHRONIC 1 0.0002
491 ABSCESS LIMB 1 0.0002
492 INTERVERTEBRAL DISC DISORDER 1 0.0002
493 PRODUCT CONTAINER ISSUE 2 0.0002
494 BLOOD MAGNESIUM DECREASED 2 0.0002
495 HORDEOLUM 1 0.0002
496 PYELONEPHRITIS 2 0.0002
497 RESPIRATORY TRACT INFECTION 6 0.0002
498 PLATELET COUNT INCREASED 3 0.0002
499 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
500 DIVERTICULUM INTESTINAL 1 0.0002
501 GASTRITIS 6 0.0002
502 LIGAMENT RUPTURE 1 0.0002
503 BLOOD CREATINE INCREASED 1 0.0002
504 PYREXIA 78 0.0002
505 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
506 DEHYDRATION 30 0.0002
507 NERVOUS SYSTEM DISORDER 7 0.0002
508 ORAL PAIN 5 0.0002
509 TACHYPNOEA 3 0.0002
510 DRUG EFFECT DELAYED 1 0.0002
511 DISEASE COMPLICATION 1 0.0002
512 UROSEPSIS 2 0.0002
513 LOCALISED OEDEMA 1 0.0002
514 HEPATIC ENCEPHALOPATHY 2 0.0002
515 ILL-DEFINED DISORDER 13 0.0002
516 HYPONATRAEMIA 12 0.0002
517 COLITIS MICROSCOPIC 1 0.0002
518 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
519 PRODUCT PRESCRIBING ERROR 5 0.0002
520 RECTAL HAEMORRHAGE 9 0.0002
521 ATELECTASIS 2 0.0002
522 LIVER FUNCTION TEST ABNORMAL 6 0.0002
523 FLUID OVERLOAD 3 0.0002
524 THROMBOTIC MICROANGIOPATHY 2 0.0002
525 PARKINSONISM 2 0.0002
526 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
527 ANAEMIA 39 0.0002
528 BREATH SOUNDS ABNORMAL 1 0.0002
529 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
530 FLUID INTAKE REDUCED 1 0.0002
531 ECONOMIC PROBLEM 3 0.0002
532 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
533 BONE MARROW FAILURE 4 0.0002
534 OXYGEN SATURATION DECREASED 11 0.0002
535 PHARYNGEAL OEDEMA 3 0.0002
536 DRUG EFFECT INCOMPLETE 7 0.0002
537 FAILURE TO THRIVE 1 0.0002
538 ACUTE MYELOID LEUKAEMIA 3 0.0002
539 EYE DISCHARGE 2 0.0002
540 MALABSORPTION 1 0.0002
541 DEAFNESS 5 0.0002
542 PRODUCT DOSE OMISSION ISSUE 56 0.0002
543 PRODUCT USE COMPLAINT 3 0.0002
544 ABDOMINAL PAIN UPPER 39 0.0002
545 RENAL PAIN 2 0.0002
546 ANAL FISTULA 1 0.0002
547 IMPAIRED WORK ABILITY 4 0.0002
548 PALLOR 5 0.0002
549 FAECALOMA 1 0.0002
550 PHOTOSENSITIVITY REACTION 3 0.0002
551 CHOKING SENSATION 1 0.0002
552 PLEURAL EFFUSION 11 0.0002
553 CYSTIC FIBROSIS 1 0.0002
554 MENTAL STATUS CHANGES 5 0.0002
555 HYPERTENSIVE CRISIS 2 0.0002
556 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
557 THROMBOCYTOPENIA 20 0.0002
558 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
559 CANDIDA INFECTION 3 0.0002
560 GENERALISED ERYTHEMA 1 0.0002
561 DERMATITIS CONTACT 2 0.0002
562 TINNITUS 8 0.0002
563 NEOPLASM 2 0.0002
564 EXERCISE TOLERANCE DECREASED 1 0.0002
565 RENAL FAILURE 23 0.0002
566 HYPERVENTILATION 1 0.0002
567 METABOLIC DISORDER 1 0.0002
568 URINARY TRACT INFECTION 29 0.0002
569 PRODUCT USE IN UNAPPROVED INDICATION 42 0.0002
570 DRUG ERUPTION 3 0.0002
571 NEUROPATHY PERIPHERAL 16 0.0002
572 CHOLECYSTITIS 2 0.0002
573 RESPIRATORY DISORDER 5 0.0002
574 POLYNEUROPATHY 2 0.0002
575 C-REACTIVE PROTEIN INCREASED 6 0.0002
576 ENCEPHALOPATHY 4 0.0002
577 HYPOACUSIS 7 0.0002
578 LARYNGEAL OEDEMA 1 0.0002
579 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
580 GENERALISED OEDEMA 2 0.0002
581 SECRETION DISCHARGE 2 0.0002
582 HEPATIC CIRRHOSIS 3 0.0002
583 NAUSEA 125 0.0002
584 GASTROINTESTINAL DISORDER 14 0.0002
585 ENTERITIS 1 0.0002
586 THROAT IRRITATION 7 0.0002
587 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
588 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
589 VOMITING 73 0.0002
590 INFUSION SITE PAIN 2 0.0002
591 ERUCTATION 3 0.0002
592 INCOHERENT 1 0.0002
593 OFF LABEL USE 135 0.0002
594 ASPERGILLUS INFECTION 1 0.0002
595 BEDRIDDEN 2 0.0002
596 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 27 0.0001
597 CARDIAC FAILURE 12 0.0001
598 PRODUCT PHYSICAL ISSUE 3 0.0001
599 FEEDING DISORDER 3 0.0001
600 NEUTROPENIA 20 0.0001
601 ABNORMAL LOSS OF WEIGHT 1 0.0001
602 RASH ERYTHEMATOUS 7 0.0001
603 PERIPHERAL COLDNESS 2 0.0001
604 EXPOSURE DURING PREGNANCY 9 0.0001
605 NIGHTMARE 5 0.0001
606 LARGE INTESTINE POLYP 1 0.0001
607 FORMICATION 1 0.0001
608 APHONIA 2 0.0001
609 ABDOMINAL DISCOMFORT 24 0.0001
610 DUODENAL ULCER 1 0.0001
611 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
612 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
613 MYELODYSPLASTIC SYNDROME 2 0.0001
614 CONSTIPATION 30 0.0001
615 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
616 FEBRILE NEUTROPENIA 9 0.0001
617 TACHYCARDIA 12 0.0001
618 CHEST PAIN 25 0.0001
619 ARTHROPOD BITE 1 0.0001
620 IMMUNODEFICIENCY 2 0.0001
621 NERVOUSNESS 7 0.0001
622 HYDRONEPHROSIS 1 0.0001
623 GENERAL SYMPTOM 1 0.0001
624 BLOOD POTASSIUM DECREASED 4 0.0001
625 OSTEOPENIA 2 0.0001
626 CHRONIC KIDNEY DISEASE 10 0.0001
627 OEDEMA PERIPHERAL 16 0.0001
628 ACIDOSIS 1 0.0001
629 INSURANCE ISSUE 2 0.0001
630 FOOD ALLERGY 1 0.0001
631 MUSCULOSKELETAL CHEST PAIN 2 0.0001
632 HYPOALBUMINAEMIA 1 0.0001
633 GASTROINTESTINAL INFLAMMATION 1 0.0001
634 MULTIPLE ALLERGIES 1 0.0001
635 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
636 COMA 6 0.0001
637 PRODUCTIVE COUGH 6 0.0001
638 PRODUCT STORAGE ERROR 11 0.0001
639 MYASTHENIA GRAVIS 1 0.0001
640 PRODUCT DOSE OMISSION 8 0.0001
641 ASPHYXIA 1 0.0001
642 ABASIA 3 0.0001
643 STAPHYLOCOCCAL INFECTION 4 0.0001
644 VENTRICULAR TACHYCARDIA 2 0.0001
645 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
646 EOSINOPHIL COUNT INCREASED 1 0.0001
647 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
648 URINARY RETENTION 4 0.0001
649 LIVE BIRTH 1 0.0001
650 HAEMODIALYSIS 1 0.0001
651 FACE OEDEMA 2 0.0001
652 WEIGHT DECREASED 33 0.0001
653 INFECTION 17 0.0001
654 HYPOPHAGIA 3 0.0001
655 FACIAL PARALYSIS 1 0.0001
656 THERAPY CESSATION 6 0.0001
657 HAEMATURIA 4 0.0001
658 INFLAMMATION 6 0.0001
659 HAEMATOMA 3 0.0001
660 MYOPATHY 1 0.0001
661 MULTI-ORGAN FAILURE 2 0.0001
662 HAEMORRHAGE 12 0.0001
663 NEUROTOXICITY 2 0.0001
664 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 23 0.0001
665 DRUG INTERACTION 18 0.0001
666 EAR INFECTION 3 0.0001
667 FACIAL PAIN 1 0.0001
668 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
669 ERYTHEMA 23 0.0001
670 MYOSITIS 1 0.0001
671 GASTROENTERITIS VIRAL 2 0.0001
672 RASH PRURITIC 6 0.0001
673 ACCIDENTAL OVERDOSE 4 0.0001
674 ASTHENIA 41 0.0001
675 BRAIN NEOPLASM 1 0.0001
676 DIVERTICULITIS 3 0.0001
677 FEELING COLD 3 0.0001
678 EYE SWELLING 4 0.0001
679 HEPATIC FUNCTION ABNORMAL 4 0.0001
680 NEPHROPATHY 1 0.0001
681 APPENDICITIS 1 0.0001
682 HYPOAESTHESIA 16 0.0001
683 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
684 FLANK PAIN 1 0.0001
685 ARTERIOSCLEROSIS 1 0.0001
686 BLOOD SODIUM DECREASED 2 0.0001
687 MUSCULOSKELETAL DISORDER 2 0.0001
688 PNEUMONIA 34 0.0001
689 HOSPITALISATION 16 0.0001
690 DRUG PRESCRIBING ERROR 2 0.0001
691 DECREASED APPETITE 24 0.0001
692 MALAISE 45 0.0001
693 AUTOIMMUNE DISORDER 1 0.0001
694 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
695 ASCITES 3 0.0001
696 CONDITION AGGRAVATED 31 0.0001
697 HEPATOMEGALY 1 0.0001
698 HOSPICE CARE 1 0.0001
699 DISABILITY 2 0.0001
700 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
701 HEART RATE INCREASED 10 0.0001
702 UPPER LIMB FRACTURE 2 0.0001
703 FEELING ABNORMAL 24 0.0001
704 DRY MOUTH 8 0.0001
705 EYELID PTOSIS 1 0.0001
706 DRY THROAT 1 0.0001
707 DISCOMFORT 6 0.0001
708 MOTOR DYSFUNCTION 1 0.0001
709 BODY TEMPERATURE INCREASED 2 0.0001
710 EAR DISCOMFORT 1 0.0001
711 PRODUCT PREPARATION ERROR 2 0.0001
712 HELICOBACTER INFECTION 1 0.0001
713 CARDIAC ARREST 8 0.0001
714 POLLAKIURIA 4 0.0001
715 JOINT DISLOCATION 1 0.0001
716 FULL BLOOD COUNT ABNORMAL 1 0.0001
717 CYSTITIS 3 0.0001
718 EATING DISORDER 2 0.0001
719 RETCHING 2 0.0001
720 BREAST PAIN 1 0.0001
721 JOINT INJURY 2 0.0001
722 HIP FRACTURE 3 0.0001
723 ATRIAL FIBRILLATION 9 0.0001
724 VIRAL INFECTION 3 0.0001
725 FUNGAL INFECTION 3 0.0001
726 MEDICATION ERROR 5 0.0001
727 HYPOTENSION 18 0.0001
728 URTICARIA 15 0.0001
729 PANCREATITIS ACUTE 2 0.0001
730 CHROMATURIA 2 0.0001
731 EYE INFECTION 1 0.0001
732 HEPATIC ENZYME INCREASED 6 0.0001
733 IMPAIRED DRIVING ABILITY 1 0.0001
734 CHOLECYSTECTOMY 1 0.0001
735 SUICIDAL IDEATION 8 0.0001
736 MUSCLE SPASMS 16 0.0001
737 SHOCK 2 0.0001
738 CONFUSIONAL STATE 14 0.0001
739 EYELID OEDEMA 1 0.0001
740 INFLUENZA LIKE ILLNESS 7 0.0001
741 DYSPNOEA 48 0.0001
742 DISEASE PROGRESSION 10 0.0001
743 PLATELET COUNT DECREASED 9 0.0001
744 MYOCLONUS 1 0.0001
745 CEREBRAL HAEMORRHAGE 3 0.0001
746 MOBILITY DECREASED 6 0.0001
747 BLOOD PRESSURE FLUCTUATION 2 0.0001
748 INTERSTITIAL LUNG DISEASE 4 0.0001
749 DEATH 71 0.0001
750 LUNG DISORDER 4 0.0001
751 FEELING HOT 5 0.0001
752 LIVER INJURY 2 0.0001
753 DYSPEPSIA 8 0.0001
754 BRONCHITIS 6 0.0001
755 FATIGUE 63 0.0001
756 HYPERSENSITIVITY 15 0.0001
757 CYST 1 0.0001
758 DYSPNOEA EXERTIONAL 3 0.0001
759 BRAIN OEDEMA 1 0.0001
760 FLUSHING 8 0.0001
761 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
762 DEVICE DEPLOYMENT ISSUE 1 0.0001
763 UNRESPONSIVE TO STIMULI 2 0.0001
764 HIATUS HERNIA 1 0.0001
765 RASH GENERALISED 2 0.0001
766 EXPOSURE VIA SKIN CONTACT 2 0.0001
767 MUCOSAL INFLAMMATION 2 0.0001
768 SEDATION 2 0.0001
769 DYSMENORRHOEA 1 0.0001
770 BLOOD PRESSURE DECREASED 5 0.0001
771 ABORTION SPONTANEOUS 3 0.0001
772 CARDIAC DISORDER 7 0.0001
773 JOINT RANGE OF MOTION DECREASED 1 0.0001
774 JAUNDICE 2 0.0001
775 THROAT TIGHTNESS 2 0.0001
776 NEUTROPHIL COUNT DECREASED 3 0.0001
777 IMPAIRED GASTRIC EMPTYING 1 0.0001
778 AKATHISIA 1 0.0001
779 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
780 PAIN IN JAW 2 0.0001
781 DIZZINESS 35 0.0001
782 BRONCHOSPASM 1 0.0001
783 RED BLOOD CELL COUNT DECREASED 2 0.0001
784 HERPES ZOSTER 4 0.0001
785 LETHARGY 4 0.0001
786 BACK PAIN 16 0.0001
787 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
788 INTENTIONAL PRODUCT MISUSE 6 0.0001
789 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
790 SURGERY 4 0.0001
791 ILLNESS 7 0.0001
792 PRURITUS 26 0.0001
793 LIVER DISORDER 3 0.0001
794 WHEEZING 4 0.0001
795 HAEMORRHAGE INTRACRANIAL 1 0.0001
796 TREMOR 11 0.0001
797 ALOPECIA 13 0.0001
798 BLOOD COUNT ABNORMAL 1 0.0001
799 NEPHROLITHIASIS 3 0.0001
800 DRUG ADMINISTRATION ERROR 2 0.0001
801 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
802 RENAL DISORDER 3 0.0001
803 SWOLLEN TONGUE 2 0.0001
804 BRAIN FOG 1 0.0001
805 DRUG-INDUCED LIVER INJURY 2 0.0001
806 CYANOSIS 1 0.0001
807 ARTHRITIS 5 0.0001
808 INFLUENZA 7 0.0001
809 COVID-19 11 0.0001
810 ABSCESS 1 0.0001
811 CONTUSION 6 0.0001
812 HYPERHIDROSIS 8 0.0001
813 RASH 27 0.0001
814 MUSCLE TIGHTNESS 1 0.0001
815 MUSCULAR WEAKNESS 7 0.0001
816 BLOOD POTASSIUM INCREASED 1 0.0001
817 DEPRESSION 14 0.0001
818 SWELLING FACE 4 0.0001
819 CHOLELITHIASIS 2 0.0001
820 METASTASES TO BONE 1 0.0001
821 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
822 DRUG LEVEL INCREASED 1 0.0001
823 FALL 20 0.0001
824 LEUKOPENIA 3 0.0001
825 PALPITATIONS 7 0.0001
826 ANXIETY 17 0.0001
827 CELLULITIS 3 0.0001
828 TOXICITY TO VARIOUS AGENTS 10 0.0001
829 GASTRIC DISORDER 2 0.0001
830 MUSCULOSKELETAL DISCOMFORT 1 0.0001
831 DELIRIUM 2 0.0001
832 DEVICE USE ISSUE 1 0.0001
833 COLD SWEAT 1 0.0001
834 SLEEP DISORDER 4 0.0001
835 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
836 HEAD DISCOMFORT 1 0.0001
837 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
838 ISCHAEMIC STROKE 1 0.0001
839 GALLBLADDER DISORDER 1 0.0001
840 THERAPY INTERRUPTED 4 0.0001
841 SKIN BURNING SENSATION 4 0.0001
842 CRYING 2 0.0001
843 PANIC ATTACK 2 0.0001
844 LOSS OF CONSCIOUSNESS 7 0.0001
845 DYSURIA 2 0.0001
846 ANAPHYLACTIC REACTION 3 0.0001
847 OROPHARYNGEAL PAIN 5 0.0001
848 ARTHROPATHY 3 0.0001
849 CONJUNCTIVITIS 1 0.0001
850 WEIGHT INCREASED 12 0.0001
851 COUGH 15 0.0001
852 BLISTER 3 0.0001
853 DYSARTHRIA 2 0.0001
854 INTESTINAL OBSTRUCTION 2 0.0001
855 UNEVALUABLE EVENT 4 0.0001
856 GASTRIC ULCER 1 0.0001
857 FEELING JITTERY 1 0.0001
858 BLOOD PRESSURE INCREASED 8 0.0001
859 LOWER LIMB FRACTURE 1 0.0001
860 PRODUCT QUALITY ISSUE 7 0.0001
861 HAEMORRHOIDS 1 0.0001
862 DISORIENTATION 2 0.0001
863 HAEMATOCRIT DECREASED 1 0.0001
864 CARDIAC FAILURE CONGESTIVE 4 0.0000
865 JOINT SWELLING 6 0.0000
866 STOMATITIS 3 0.0000
867 EXTRA DOSE ADMINISTERED 2 0.0000
868 DYSKINESIA 2 0.0000
869 BLINDNESS 2 0.0000
870 CHEST DISCOMFORT 5 0.0000
871 HAEMOGLOBIN DECREASED 5 0.0000
872 DRUG DOSE OMISSION 8 0.0000
873 RHABDOMYOLYSIS 2 0.0000
874 HEADACHE 30 0.0000
875 CARDIO-RESPIRATORY ARREST 2 0.0000
876 DERMATITIS 1 0.0000
877 RENAL IMPAIRMENT 4 0.0000
878 MOUTH ULCERATION 1 0.0000
879 PAIN 29 0.0000
880 BALANCE DISORDER 4 0.0000
881 DEEP VEIN THROMBOSIS 3 0.0000
882 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
883 ANGIOEDEMA 2 0.0000
884 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
885 NEOPLASM MALIGNANT 3 0.0000
886 GLOSSODYNIA 1 0.0000
887 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
888 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
889 ADVERSE DRUG REACTION 4 0.0000
890 PARAESTHESIA 7 0.0000
891 HEART RATE IRREGULAR 1 0.0000
892 INCORRECT DOSE ADMINISTERED 10 0.0000
893 MEMORY IMPAIRMENT 6 0.0000
894 MUSCLE TWITCHING 1 0.0000
895 SEIZURE 5 0.0000
896 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
897 BURNING SENSATION 3 0.0000
898 ARRHYTHMIA 2 0.0000
899 MIGRAINE 4 0.0000
900 DRUG INTOLERANCE 4 0.0000
901 MENTAL IMPAIRMENT 1 0.0000
902 UNDERDOSE 3 0.0000
903 CEREBRAL INFARCTION 1 0.0000
904 DYSGEUSIA 3 0.0000
905 DRY EYE 2 0.0000
906 SOMNOLENCE 8 0.0000
907 GASTRIC CANCER 1 0.0000
908 SINUSITIS 4 0.0000
909 PERIPHERAL SWELLING 6 0.0000
910 DIPLOPIA 1 0.0000
911 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
912 JOINT STIFFNESS 1 0.0000
913 PANCREATITIS 2 0.0000
914 DEPRESSED MOOD 2 0.0000
915 BRADYCARDIA 2 0.0000
916 INSOMNIA 10 0.0000
917 PAIN IN EXTREMITY 11 0.0000
918 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
919 FEAR 1 0.0000
920 DRUG EFFECT DECREASED 2 0.0000
921 BLOOD BILIRUBIN INCREASED 1 0.0000
922 OEDEMA 2 0.0000
923 MOOD ALTERED 1 0.0000
924 ABNORMAL DREAMS 1 0.0000
925 HAEMOPTYSIS 1 0.0000
926 DEMENTIA 1 0.0000
927 SKIN EXFOLIATION 3 0.0000
928 EYE PAIN 2 0.0000
929 CEREBROVASCULAR ACCIDENT 6 0.0000
930 MYALGIA 6 0.0000
931 INTENTIONAL DOSE OMISSION 1 0.0000
932 DYSSTASIA 1 0.0000
933 DYSPHONIA 2 0.0000
934 ACUTE MYOCARDIAL INFARCTION 1 0.0000
935 LABORATORY TEST ABNORMAL 1 0.0000
936 HEPATIC FAILURE 1 0.0000
937 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
938 CORONARY ARTERY DISEASE 1 0.0000
939 THERAPEUTIC RESPONSE DECREASED 2 0.0000
940 VERTIGO 2 0.0000
941 EPILEPSY 1 0.0000
942 LIMB DISCOMFORT 1 0.0000
943 VISUAL IMPAIRMENT 4 0.0000
944 SWELLING 3 0.0000
945 HYPOTHYROIDISM 1 0.0000
946 MOVEMENT DISORDER 1 0.0000
947 LACTIC ACIDOSIS 1 0.0000
948 EYE DISORDER 1 0.0000
949 EXPIRED PRODUCT ADMINISTERED 1 0.0000
950 EYE PRURITUS 1 0.0000
951 NEOPLASM PROGRESSION 1 0.0000
952 MYOCARDIAL INFARCTION 5 0.0000
953 HEART RATE DECREASED 1 0.0000
954 DEVICE MALFUNCTION 2 0.0000
955 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
956 HYPERGLYCAEMIA 1 0.0000
957 AGITATION 2 0.0000
958 ASTHMA 3 0.0000
959 HALLUCINATION 2 0.0000
960 DIABETES MELLITUS 2 0.0000
961 GAIT DISTURBANCE 5 0.0000
962 THROMBOSIS 2 0.0000
963 DEVICE BREAKAGE 1 0.0000
964 LUNG NEOPLASM MALIGNANT 1 0.0000
965 ARTHRALGIA 10 0.0000
966 MENTAL DISORDER 1 0.0000
967 DRY SKIN 3 0.0000
968 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
969 PULMONARY EMBOLISM 2 0.0000
970 HYPOGLYCAEMIA 1 0.0000
971 SYNCOPE 2 0.0000
972 FLUID RETENTION 1 0.0000
973 MUSCULOSKELETAL PAIN 1 0.0000
974 RHEUMATOID ARTHRITIS 2 0.0000
975 CONVULSION 1 0.0000
976 EYE IRRITATION 1 0.0000
977 BONE PAIN 1 0.0000
978 IRRITABILITY 1 0.0000
979 BLOOD GLUCOSE INCREASED 3 0.0000
980 INTENTIONAL OVERDOSE 1 0.0000
981 AMNESIA 1 0.0000
982 VISION BLURRED 2 0.0000
983 HYPERTENSION 3 0.0000
984 OVERDOSE 3 0.0000
985 EPISTAXIS 1 0.0000
986 MUSCULOSKELETAL STIFFNESS 1 0.0000
987 DRUG WITHDRAWAL SYNDROME 1 0.0000
988 DEVICE ISSUE 1 0.0000
989 BREAST CANCER 1 0.0000
990 EMOTIONAL DISTRESS 1 0.0000
991 NASOPHARYNGITIS 1 0.0000